ARC Medical Private Investor Briefing – Virtual

Event Details

ARC Medical Private Investor Briefing - Virtual

by CONNECTpreneur Investor Network

TUESDAY, May 19, 2026

Please note that this meeting is for DIRECT and ACTIVE investors only. All RSVPs must be pre-registered on this Eventbrite site with the investor criteria filled out. All RSVPs are subject to review and approval.

Please join us for an invitation only virtual private investor meeting on Zoom, featuring ARC Medical, on Tuesday, May 19, 2026.

This session is hosted by Opus8 in collaboration with the New York Private Equity Forums (NYPEF).

ARC is one of the most exciting life sciences companies we have seen! ARC significantly improves surgical patient recovery by preventing internal adhesions, the most common complication in knee, shoulder, gynecological and abdominal surgeries.

Recent Clinical & Product Highlights

JOCOAT™ (Orthopedic Surgeries – Knee & Shoulder)
• Successfully used in 20 patients (expanded access: knee + shoulder)
• First 9 patients enrolled in ongoing ACL reconstruction clinical trial (GLAD-04)

IPCOAT™ (Gynecologic & Abdominal Surgeries)
• First patient treated in complex laparoscopic procedure
• No adhesions observed at 6-week follow-up
• Clinical trial (GLAD-02, endometriosis) progressing through regulatory review

Key Investment Considerations

Massive Markets: 11 million patients yearly and a TAM $11 billion
Excellent Efficacy and Clinical Data: for company’s lead products for knee and shoulder surgeries
Strong IP Provide Exclusivity: multiple patents granted that provide exclusivity for the company’s products through 2039 and beyond.
Great Fundrasing traction: ARC has already raised $39 million ($21M in equity and $18M in non-dilutive revenue and grants), and will close the current round in a matter of weeks.
Unicorn-level Exit Potential: representing a 20X return based on comparable companies in the wound healing arena.
World Class Team: has designed, developed multi $billion products for companies including J&J, Stryker, Smith+Nephew, Amgen and Moderna

Event Details

Date: May 19, 2026

Time: 11:30 AM – 12:30 PM EDT

Location: Online via Zoom

Important Notes

Please note that this meeting is for DIRECT and ACTIVE investors only. All RSVPs must be pre-registered on this Eventbrite site with the investor criteria filled out. All RSVPs are subject to review and approval.

To request investor materials, contact:
Avery North — anorth@opus8.com

Event Details